Drug factory · FDA FEI 3003005071
PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd.
No. 11, Weiqi Road, Hangzhou Bay Shangyu Economic and Technological Development Area, Shaoxing, China
No problems found at FDA's last inspection, Jul 5, 2019.
No Action Indicated: inspectors found no objectionable conditions.
1 drug inspection on record since 2019: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Ziftomenib | Makes the active ingredient and tests it | Kura Oncology, Inc. | 84696-200 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 5, 2019 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; pack.